AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/article-1G1-76737366/de-novo-pharmaceuticals-venture.html" title="Facts and information about DE NOVO Pharmaceuticals.(venture financing)(Brief Article)">DE NOVO Pharmaceuticals.(venture financing)(Brief Article)</a>
Close
Set up an RSS feed that alerts you when new articles from The Daily Deal are available.
Frequently asked questions about RSS feeds
DE NOVO Pharmaceuticals.(venture financing)(Brief Article)
Cambridge, Mass.-based drug design company DE NOVO Pharmaceuticals closed on a $24 million venture financing round led by Merlin Biosciences, along with Prelude Trust and Avlar BioVentures, The Sunday …
Related articles from newspapers, magazines, journals, and more
-
- Press Release: De Novo Pharmaceuticals to assume responsibility for CeNeS...
-
News wire article from: Chemical Business Newsbase
December 11, 2001
700+ words
-
- De Novo Pharmaceuticals and Peakdale Molecular announce strategic alliance.
-
News wire article from: Asia Africa Intelligence Wire
April 1, 2003
700+ words
-
- De Novo Pharmaceuticals Ltd and Roche announce the successful creation of a...
-
News wire article from: Asia Africa Intelligence Wire
February 17, 2003
700+ words
-
- PRESS RELEASE: De Novo Pharmaceuticals Ltd announces deployment of integrated...
-
News wire article from: Chemical Business Newsbase
April 11, 2001
700+ words
-
- De Novo Pharmaceuticals announces drug discovery collaboration with Genzyme.
-
News wire article from: Chemical Business Newsbase
January 17, 2006
700+ words
